Maynard Um
-
-
-
-
-
-
-
Truist on Insmed (INSM): Brinsupri Launch Outpacing Most Bullish Expectations
-
-
-
-
-
-
-
Insmed (INSM) PT Lowered to $241 at TD Cowen as 'Ph2 Brenso BiRCh Misses'
-
-
-
-
-
-
-
Insmed (INSM) PT Lowered to $167 at Wolfe Research
-
-
-
-
-
-
-
Rothschild Redburn Starts Insmed (INSM) at Buy
-
-
-
-
-
-
-
Cantor Fitzgerald Assumes Insmed (INSM) at Overweight
-
-
-
-
-
-
-
Insmed (INSM) PT Raised to $172 at Guggenheim, 'continue to see it as a Top Pick'
-
-
-
-
-
-
-
Insmed (INSM) PT Raised to $145 at Stifel
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

